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Background: The purpose of this study was to determine demographic and psychosocial factors that
inﬂuence the effectiveness of cooled radiofrequency genicular nerve ablation (C-RFA) and block in patients with chronic knee pain secondary to osteoarthritis (OA).
Methods: A retrospective review was completed including patients with knee OA who underwent
genicular nerve ablation or block or both. Patient information collected included opioid use, psychological comorbidities, smoking history, body mass index, and medical comorbidities. Success was deﬁned
using the Osteoarthritis Research Society International criterion of greater than or equal to 50% reported
pain relief from the procedure. Patients without a diagnosis of knee OA and patients with ipsilateral total
knee arthroplasty were excluded. Patient factors were compared between (1) those that did or did not
respond to the initial block and (2) those that did or did not respond to C-RFA.
Results: Of the 176 subjects that underwent genicular nerve block, 31.8% failed to respond to the procedure. Subjects that failed the initial block were signiﬁcantly more likely to have psychological
comorbidities, smoking history, and diabetes. Of the subjects that proceeded to genicular nerve ablation,
53.7% reported less than 50% pain relief, and 46.3% reported pain relief greater than or equal to 50% at the
ﬁrst follow-up visit. While the presence of psychological comorbidities, smoking, and diabetes were
associated with ﬁrst-stage block failures, these patient factors were not associated with second-stage
ablation failures.
Conclusions: C-RFA may be an effective adjunct therapy as part of a multimodal pain regimen; however,
individual patient characteristics must be considered.
© 2020 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Introduction
Knee osteoarthritis (OA) has substantially increased in prevalence in developed nations since the postindustrial era; longer life
expectancy, increased body mass index (BMI), and other independent variables have been implicated in this rise in prevalence [1].
Knee pain associated with OA has been shown to be an independent risk factor for early mortality, and, thus, reducing knee OA pain
is a global health concern [2]. Generally, the treatment goals for
knee OA include improving patient function and alleviating pain,
initially with conservative therapy consisting of physical therapy,
nonsteroidal anti-inﬂammatory medications, and intraarticular
corticosteroid injection [3]. When conservative treatment fails to
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meet these goals, surgical intervention with total knee arthroplasty
(TKA) is an excellent option to improve patient function and relieve
pain [3,4]. As estimated by Weinstein et al. [5], 52.2% of males and
50.6% of females who are diagnosed with symptomatic knee OA
will undergo TKA during their lifetime.
Few options exist for patients who fail initial conservative
treatment options and desire to postpone TKA or for those who are
poor surgical candidates. Cooled radiofrequency genicular nerve
ablation (C-RFA) has been introduced as a safe, minimally invasive
alternative for these patients [6]. The procedure is performed using
a thermal probe that is directed using ﬂuoroscopy or ultrasound to
well-described and validated bony landmarks in the paths of the
genicular nerves [7]. A current is applied through the probe to
induce a thermal injury to the targeted nerve, which, in turn, disrupts the neurosignaling of pain sensation from the knee capsule.
A patient initially undergoes a diagnostic genicular nerve block
with local anesthetic. If the nerve block is successful in alleviating
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the patient’s pain, cooled radiofrequency ablation is performed of
the superior medial, superior lateral, and inferior medial genicular
nerves. Ablation of the inferior lateral genicular nerves is frequently
avoided because of their close proximity to the common peroneal
nerve. Genicular nerve C-RFA has been shown to be effective in
reducing chronic knee pain for up to 6 months [8-14]. This provides a
potential long-term therapeutic option for patients with signiﬁcant
medical comorbidities and those who desire to delay or avoid TKA.
However, demographic factors that contribute to success or
failure of genicular nerve C-RFA have not been fully elucidated.
Predictors of success and failure have been studied in the use of
radiofrequency ablation in other regions, namely the sacroiliac joint
and lumbar and cervical facets. Increased age, higher baseline pain
level, previous surgery, history of depression, and opioid use have
been found to be associated with failure of the procedure [15]. The
effect of psychosocial factors on pain perception in knee OA is well
documented, but has not been studied in regard to genicular nerve
ablation [16]. Understanding how these factors affect outcomes can
assist the surgeon with making more targeted treatment decisions.
The purpose of the present study was to determine the demographic and psychosocial factors that inﬂuence the effectiveness
of genicular nerve block and C-RFA in patients with knee OA.
Material and methods
An institutional review boardeapproved retrospective chart review was completed using the Electronic Medical Record at our
institution. Patients were initially identiﬁed by performing a search
with corresponding Common Procedural Terminology codes
(64,450, 64,640). Patients who had undergone genicular nerve block
and C-RFA with a diagnosis of knee OA, deﬁned by the American
College of Rheumatology criteria [17], were included. Patients undergoing traditional radiofrequency nerve ablation, patients without
a diagnosis of knee OA, patients undergoing ablation after TKA, and
patients with insufﬁcient charted data were excluded.
All patients underwent C-RFA or block between January 2015
and September 2017 at a single institution. C-RFA was performed by
the interventional pain specialists at our institution. Local anesthesia consisted of 1% lidocaine at each ablation site. Three milliliters of 2% lidocaine without epinephrine was then injected at each
site, and the cooled radiofrequency ablation was undertaken at
60 C for 2 minutes and 30 seconds at each site. After ablation, 1 mL
of steroid solution containing 0.25% bupivacaine and 40 mg of
Depo-Medrol was injected at each site.
Patient information collected included demographic information (age, sex, BMI), opioid medication use (deﬁned as an active
prescription for greater than 1 month before procedure), selfreported psychological comorbidities, smoking history, and medical comorbidities. Patient-reported percent pain relief immediately
after the genicular nerve block was recorded using a Visual Analog
Scale as percentage of pain relief (0%-100%) and was also recorded
at the ﬁrst follow-up after genicular nerve ablation (range 4 to 6
weeks). Success of the block or ablation was deﬁned using Osteoarthritis Research Society International criteria of greater than 50%
reported pain relief from the procedure [18].
Patient factors were compared between (1) those that did or did
not respond to the initial block and (2) those that did or did not
respond to C-RFA. Continuous variables were compared between responders and nonresponders using 2-tailed independent t-tests, and
categorical variables were compared using Chi-square or Fisher exact
as appropriate. An alpha level of P < .05 was considered statistically
signiﬁcant, and all analyses were performed using SPSS Statistics 24
(IBM, Armonk, NY). The prevalence of patients with >50% pain relief
was also compared based on Kellgren-Lawrence Classiﬁcation (K-L
Classiﬁcation) using chi-square and Fisher Exact tests as appropriate.
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Table 1
Comparison of knee OA patients that did vs did not respond to genicular nerve block.
Patient variables

Responders

Nonresponders

P value

N, %
Age (N ± SD)
BMI
Tobacco use (N, %)
Sex (M, F)
Mental health Dx (N, %)
Diabetes mellitus (N, %)
Opioid use (ME ± SD)

120, 68.2%
58 ± 12.3
38.7 ± 10.4
26, 31.0%
53, 67
36, 30%
28, 23%
21.1 ± 39.3

56, 31.8%
55 ± 10.6
36.0 ± 9.0
31, 69%
21, 35
30, 55%
41, 75%
13.8 ± 37.3

e
.603
.099
<.001
.252
.002
<.001
.262

BMI, body mass index; F, female; M, male; ME, morphine equivalents; OA, osteoarthritis; SD, standard deviation.

Results
Genicular nerve block
One hundred seventy-six knees were identiﬁed that met inclusion criteria and underwent genicular nerve block (Table 1). Of
those, 56 (31.8%) failed to experience greater than or equal to 50%
pain relief on the initial block and did not proceed to undergo
ablation. Subjects that failed the initial block were signiﬁcantly
more likely to have self-reported psychological comorbidities,
including anxiety and depression (P ¼ .002). Those who failed the
block also had a greater proportion of patients with a smoking
history (P < .001) and diabetes mellitus (DM) (P < .001) than those
with successful blocks. There were no signiﬁcant differences between the 2 groups in age, morphine milligram equivalent dosage,
gender, or BMI.
Genicular nerve ablation
One hundred twenty knees with successful genicular nerve
blocks underwent genicular nerve ablation. Follow-up data were
unavailable for 25 subjects after ablation and were excluded from
analysis (Fig. 1). Of the 95 knees with follow-up data 4 to 6 weeks
after C-RFA ablation, 44 (46.3%) experienced greater than or equal

Genicular Nerve
Block
(n=176)

Block Nonresponders
(n=56, 31.8%)
Block Responders
(n=120, 68.2%)

Lost to Follow-up
(n=25, 20.8%)

C-RFA Responders
(n=44, 46.3%)

C-RFA Non(n=51, 53.7%)

Figure 1. Patients undergoing cooled radiofrequency genicular nerve ablation (C-RFA)
must ﬁrst undergo a diagnostic genicular nerve block and experience at least 50% pain
relief on a Visual Analog Scale. The ﬁgure outlines the response rate to block and C-RFA
in our patient population.
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to 50% pain relief, and 51 (53.7%) failed to experience greater than
or equal to 50% pain relief. No signiﬁcant differences were found in
the demographic characteristics between those who failed and
those who had successful ablation, including psychological
comorbidities, smoking history, DM, gender, age, or opioid use
(Table 2). The average percent pain improvement at the postablation follow-up was 36.7% (standard deviation, 36.2). Of all,
57.9% of subjects reported some reduction in pain, while 42.1% reported no reduction in pain. Repeat C-RFA was performed in 21
(18%) subjects. Follow-up data were available for 16 of the 21 repeat
ablations, with 56% reporting greater than 50% pain relief. Of the
patients reporting greater than 50% pain relief after repeat C-RFA,
only 37.5% experienced greater than 50% pain relief after the ﬁrst CRFA. Signiﬁcantly fewer patients with K-L grade 4 radiographic
changes had >50% pain relief (11/38, 28.9%) when compared to
both K-L grade 2 (13/21, 61.9%, P ¼ .03) and K-L grade 3 (16/30,
53.3%, P ¼ .049). There was no difference between K-L grade 2 and 3
(P ¼ .58). When combining the K-L grade 2 and 3 patients, K-L grade
4 patients were signiﬁcantly more likely to have pain relief <50%
with genicular nerve ablation (odds ratio ¼ 3.2, 95% conﬁdence
interval: 1.3 to 7.9, P ¼ .01). No major adverse events were reported
after the block or C-RFA procedures.
Discussion
Knee pain from OA is an increasing problem encountered by
orthopedic surgeons. However, many patients are unable to ﬁnd
relief with conservative management or are poor candidates for
TKA because of other medical comorbidities. Genicular nerve C-RFA
offers a less invasive option that has been shown to be effective in
treating OA knee pain for up to 6 months or longer [19]. However,
demographic factors inﬂuencing the success of this procedure have
not yet been fully elucidated. Knowledge of these factors is vital for
the orthopaedist to appropriately select patients that may beneﬁt
from the procedure and to avoid delaying treatment of chronic
knee pain in patients that are less likely to beneﬁt from this
procedure.
A large proportion (31.8%) of the patients undergoing diagnostic
genicular nerve block failed to gain greater than 50% pain relief
from the procedure. This appears to be consistent with previously
reported literature; however, the true success rate of the block is
yet to be established as most previous studies investigating genicular nerve C-RFA fail to report this number. Patients with selfreported psychological comorbidities, smoking history, and DM
were signiﬁcantly more likely to fail genicular nerve block. This
suggests that these failures are less likely because of technical
factors, but, rather, patient-speciﬁc peripheral and central pain
processing.
Mounting evidence suggests that tobacco smoking plays a role
in chronic pain processing. Jakobsson [20] demonstrated a greater

Table 2
Comparison of knee OA patients that did vs did not respond to cooled radio frequency genicular nerve ablation.
Patient variables

Responders

Nonresponders

P value

N, %
Age (N ± SD)
BMI
Tobacco use (N, %)
Sex (M, F)
Mental health Dx (N, %)
Diabetes mellitus (N, %)
Opioid use (ME ± SD)

44, 46.3%
58.9 ± 13.0
37.4 ± 10.5
8, 24.0%
20, 31
16, 31.0%
11, 21.6%
19.9 ± 37.0

53, 53.7%
58.6 ± 13.8
40.1 ± 8.8
12, 46.0%
22, 22
11, 25.0%
8, 18.2%
24.6 ± 43.9

e
.938
.179
.361
.291
.492
.799
.589

BMI, body mass index; F, female; M, male; ME, morphine equivalents; OA, osteoarthritis; SD, standard deviation.

chronic pain intensity in smokers in a large population in Sweden.
The exact mechanism of pain modulation in smokers in not fully
established; however, Jakobsson suggested that it may be a combination of altered central pain processing and deranged local
nociception due to microvascular constriction and tissue hypoxia.
Shi et al. [21] noted several factors that contributed to the increased
incidence of chronic pain in smokers. They note that chronic
smoking leads to receptor desensitization and tolerance, and subsequent receptor upregulation, that may signiﬁcantly alter the local
processing within analgesic pathways. Moreover, chronic smoking
causes downregulation of the stress response in the sympathetic
system and hypothalamic-pituitary-adrenal axis, systems which
generally decrease perception of pain, causing dysregulation of
ventral pain processing. Shi et al. [21] additionally note that chronic
smoking is associated with many psychosocial factors such as
depression, low socioeconomic status, and chronic opioid use,
which have been independently implicated in increased chronic
pain. In addition to the physiologic effects of smoking, these factors
play a complex role in the regulation of local and central pain
processing.
The macroscopic and microscopic effects of hyperglycemia on
peripheral and central nerve function are well established. Hyperglycemia leads to oxidative injury to peripheral nerves and small
ﬁbers causing dysregulation in local nociception [22]. It has been
demonstrated that, on a microscopic level, hyperglycemia causes
mitochondrial dysfunction, which plays a substantial role in peripheral neuropathies and local pain processing [23]. Thus, it is not
surprising to ﬁnd that patients with DM responded to the genicular
nerve block with less success than patients without DM. Of note, we
did not explore the individual proﬁle of each patient’s DM diagnosis, such as Hb-A1C or length of diagnosis; however, future
studies should include these variables.
Less well known are the effects of mental health disorders on
central pain processing. This is an active area of investigation, and
studies have demonstrated a substantial link between mental
health disorders and pain perception. Christensen et al. [24]
demonstrated that a prior history of depression was determined to
be a signiﬁcant predictor of neurotomy failure in zygapophyseal
joints. In addition, pain catastrophizing has been implicated as a
link between increased chronic pain and mental health disorders
[25-27]. Keefe et al. [25] demonstrated that higher catastrophizing
scores in a cohort of patients with knee OA correlated to increased
chronic pain behavior. Thus, this makes an argument for combined
C-RFA and cognitive behavioral therapy for OA patients with psychological comorbidities, as their pain does not appear to be solely
associated with local nociception, but, rather, deranged central pain
processing. Future studies are needed to determine if mental health
therapy does, in fact, have an impact on the outcome of genicular
nerve block or C-RFA.
Our results demonstrate that patients with self-reported psychological comorbidities, smoking history, and DM were signiﬁcantly more likely to fail genicular nerve block (P ¼ .002, <.001,
<.001), whereas these factors had no signiﬁcant difference between
those who failed or had success with genicular nerve C-RFA. We
believe that this observation is due to selection bias in our ablation
population. We submit that the reason our inability to demonstrate a
signiﬁcant inﬂuence of these factors on C-RFA failure is likely due to
the fact that the block failure patients, with altered pain processing,
were selectively eliminated from proceeding to C-RFA.
The utility of the genicular nerve block is still under investigation.
The study by Reddy et al. [28] in 2016 attempted to create selection
criteria for C-RFA. A threshold of 80% pain reduction from the block
resulted in >90% pain reduction after ablation, improved selfreported functionality, and avoidance of surgery at 6-month
follow-up. However, this study had a small population study of
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only 4 patients. Similarly, McCormick et al., 2017 [8], found >80%
pain relief from the block was predictive of treatment success and
reported a success rate of 35%. The present study used the 50%
threshold as outlined by Osteoarthritis Research Society International and demonstrated a 46.3% success rate for ablation. Previous
studies investigating the utility of higher cutoffs to deﬁne a successful block, mostly in cervical and lumbar RFA, have mostly
demonstrated no improvement in outcomes [29]. Our results are in
agreement with these previous studies in the spine. When applying
75 and 90% cutoff values to deﬁne success in the diagnostic block to
our cohort, we ﬁnd C-RFA success to be 42.9 and 44.9%, respectively.
We report a 46.3% C-RFA success rate. These results are less
encouraging than those found in previous trials. Choi et al., 2011
[13], reported 59% of the RF group maintained 50% pain relief at 12
weeks. Seventy-four percent of the C-RFA group maintained QARSI
criteria at 6-month follow-up in the trial by Davis et al. in 2018 [9].
Despite our C-RFA success rate of 46.3%, we believe that our results,
in combination with previously published literature, support genicular nerve C-RFA as a viable treatment option for some patients
with knee OA.
An interesting ﬁnding of our study is that signiﬁcantly fewer
patients with K-L grade 4 radiographic changes had >50% pain relief
when compared to both K-L grades 2 and 3. To our knowledge, no
other study investigating the efﬁcacy of C-RFA has stratiﬁed patients
based on Kellgren-Lawrence Classiﬁcation. This ﬁnding suggests that
patients with more advanced radiographic OA may be less likely to
beneﬁt from C-RFA. However, further prospective randomized
controlled studies are needed to further validate this ﬁnding.
This study was an analysis of effectiveness of genicular nerve
block and C-RFA; we did not perform a cost analysis; however, with
the current trend of cost-conscious medicine, one must take
health-care expenditure into consideration. The process of this
treatment requires multiple visits and, potentially, multiple procedures, which may increase cost. A recent study looking at the
health-care expenditure before TKA reported that over half of the
noninpatient costs associated with treatment of knee OA occur in
the year before TKA and concluded that a signiﬁcant reduction in
treatment cost could be achieved if only treatments supported by
Clinical Practice Guidelines were used [30]. Future studies are
needed to determine the cost-effectiveness of C-RFA.
Limitations
The limitations of this study must be addressed. First, the lack of
observed differences in patient factors between responders and
nonresponders could potentially have been due to a lack of sufﬁcient power. For this observational study, an a priori power analysis
was not performed as we could not estimate the prevalence of
those that would respond to the block or ablation, and there were
no available data in the literature to support such an analysis. Using
individual knees as subjects allows patients with bilateral knee
pain and procedures to be doubly included, possibly affecting
outcomes. However, we found that the distribution of C-RFA success vs failure in bilateral knee patients is comparable with the
remainder of the cohort with 50% success and 50% failures. As a
retrospective study, this study is subject to the lack of randomization and blinding inherent of retrospective studies. In addition, only
one outcome measure, Visual Analog Scale, was used in this study.
Analyzing more aspects of patient outcomes including functionality
and quality of life would provide a more detailed view of treatment
outcomes. Patient follow-up was limited to 6 weeks, as per the
protocol of the pain management specialists at our institution.
Furthermore, baseline pain scores were unavailable for our patient
population. Differences in baseline pain scores may variably affect
patient perspectives of pain reduction. Finally, our study may be
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affected by selection bias secondary to the nature of our patient
population. Many of the patients in this study have multiple
medical comorbidities, including chronic pain, and were specifically selected to undergo C-RFA as a means to avoid the risks of
arthroplasty and anesthesia. Thus, the results of this study may not
be generalizable to healthier patients with primary knee OA.
Conclusions
Genicular nerve C-RFA is a potential therapeutic option for patients suffering chronic knee OA pain not responsive to conservative treatment or for patients unable to undergo TKA because of
overwhelming medical comorbidities. However, patients with selfreported psychological comorbidities, DM, and tobacco smoking
are less likely to beneﬁt. The genicular nerve block may have utility
in discerning patients who will not respond to ablation because of
changes in pain processing. In conclusion, C-RFA is an effective
adjunct therapy as part of a multimodal pain regimen for many
patients with OA, but future studies are needed to fully elucidate
why some patients fail to respond.
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